Drug Trial Radar · NCT07179380
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
344
Planned (sponsor's estimate)
Start
Jan 7, 2026
Primary completion
Dec 30, 2028
Study completion Dec 30, 2028
Sponsor
- Lead sponsor
- Insmed IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Sep 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD.
Conditions
- Pulmonary Hypertension
- Interstitial Lung Disease
Interventions
Treprostinil Palmitil Inhalation PowderDrug
Oral inhalation using a capsule-based dry powder inhaler device.
PlaceboDrug
Oral inhalation using a capsule-based dry powder inhaler device.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in 6 Minute Walk Distance (6MWD) Measured at Peak Exposure From Baseline to Week 24Time frame: Baseline, Week 24
Locations
186 sites in 30 countries. Site status is shown where the registry gives one.
USA027
Phoenix, Arizona · Not yet recruiting
USA007
Fresno, California · Not yet recruiting
USA010
Los Angeles, California · Recruiting
USA023
Los Angeles, California · Recruiting
USA020
San Francisco, California · Recruiting
USA001
Santa Barbara, California · Recruiting
USA017
Gainesville, Florida · Recruiting
USA006
Naples, Florida · Recruiting
USA026
St. Petersburg, Florida · Recruiting
USA028
Tampa, Florida · Not yet recruiting
USA002
Kansas City, Kansas · Recruiting
USA005
New York, New York · Recruiting
USA022
Chapel Hill, North Carolina · Not yet recruiting
USA011
Durham, North Carolina · Recruiting
USA015
Cincinnati, Ohio · Recruiting
USA003
Bend, Oregon · Recruiting
USA013
Philadelphia, Pennsylvania · Recruiting
USA025
Salt Lake City, Utah · Not yet recruiting
USA008
Richmond, Virginia · Recruiting
ARG004
Córdoba, Argentina · Recruiting
ARG001
Córdoba, Argentina · Recruiting
ARG010
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina · Not yet recruiting
ARG005
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina · Recruiting
ARG002
CiudadAutonoma de Buenos Aires, Buenos Aires, Argentina · Recruiting
ARG003
Río Cuarto, Córdoba Province, Argentina · Recruiting
ARG011
Rosario, Santa Fe Province, Argentina · Not yet recruiting
ARG008
San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting
AUS001
Camperdown, New South Wales, Australia · Recruiting
AUS006
Kingswood, New South Wales, Australia · Recruiting
AUS005
New Lambton Heights, New South Wales, Australia · Recruiting
AUS003
Westmead, New South Wales, Australia · Recruiting
AUS004
Auchenflower, Queensland, Australia · Not yet recruiting
AUS002
South Brisbane, Queensland, Australia · Recruiting
AUT002
Innsbruck, Austria · Recruiting
AUT001
Linz, Austria · Recruiting
AUT003
Vienna, Austria · Recruiting
BEL001
Anderlecht, Belgium · Recruiting
BEL002
Leuven, Vlaams Brabant, Belgium · Recruiting
BRA002
São Paulo, Brazil · Recruiting
BRA006
São Paulo, Brazil · Recruiting
Showing 40 of 186 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.